Shoichi Ukai

Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell

Shoichi Ukai, Ririno Honma, Naoya Sakamoto et al. · Oncogene · 2020 · 62 citations

Medicine, Cancer Stem Cell, Cancer Genomics +9

Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq

Tsuyoshi Takashima, Naoya Sakamoto, Junko Murai et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2020 · 50 citations · Full text

Functional Genomics, Medicine, Dna-damaging Agents +8

Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers

Tsuyoshi Takashima, Daiki Taniyama, Naoya Sakamoto et al. · British Journal of Cancer · 2021 · 46 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +5

Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance

K Harada, Naoya Sakamoto, Shoichi Ukai et al. · Gastric Cancer · 2021 · 40 citations · Full text

Tumor Biology, Oncology, Chemoprevention Strategy +7

KHDRBS3 promotes multi‐drug resistance and anchorage‐independent growth in colorectal cancer

Shoichi Ukai, Naoya Sakamoto, Daiki Taniyama et al. · Cancer Science · 2021 · 29 citations · Full text